Search results for "hepatology"

showing 10 items of 2737 documents

Non-invasive assessment of the liver fibrosis by transient elastography (TE) in patients with transfusion-dependent thalassemia

2008

medicine.medical_specialtyHepatologybusiness.industryInternal medicineLiver fibrosisNon invasiveGastroenterologymedicineTransfusion dependent thalassemiaIn patientbusinessTransient elastographyGastroenterologyDigestive and Liver Disease
researchProduct

Definitions, methodology and therapeutic strategies in portal hypertension

1992

medicine.medical_specialtyHepatologybusiness.industryMEDLINEmedicinePortal hypertensionConsensus developmentmedicine.diseasebusinessIntensive care medicineSurgeryJournal of Hepatology
researchProduct

Biliary microbiota in pancreatic cancer

2019

The most common microorganisms were Pseudomonas spp. (P < 0.0001) and E. coli (P < 0.0001), which were negatively correlated to PDAC and positively correlated to cholangiocarcinoma by both univariate and multivariate analysis. Gram-negative bacteria are linked to a tumor-associated inflammatory status

medicine.medical_specialtyHepatologybusiness.industryMicrobiotamedicine.medical_treatmentTreatment outcomeGastroenterologyMEDLINEmedicine.diseaseGastroenterologyNeoadjuvant TherapyPancreatic NeoplasmsTreatment OutcomeBiliary tractInternal medicinePancreatic cancermedicineHumansBiliary microbiota pancreatic cancerBiliary TractbusinessNeoadjuvant therapy
researchProduct

Clinical scoring systems for predicting outcome after surgery for colorectal liver metastases: towards a better multidisciplinary approach

2009

medicine.medical_specialtyHepatologybusiness.industryMultidisciplinary approachGeneral surgeryMedicinebusinessOutcome (game theory)SurgeryLiver International
researchProduct

Acute hepatitis C: in search of the optimal approach to cure.

2006

Abstract IFN monotherapy for acute hepatitis C can be supported, but a strategy taking into account both baseline (clinical presentation, genotype, HIV coinfection) and early (spontaneous viral decay) virologic response should be developed from carefully conducted, controlled prospective studies comparing a “wait and see strategy”, and different schedules of PEG IFN monotherapy to optimize adherence and costs and to reduce the number needed to treat. The price of the ultimate success of therapy for AVH due to HCV, i.e. a stable and definitive clearance of HCV with no residual liver disease in the long term, should not be paid by a high number of patients who are treated needlessly.

medicine.medical_specialtyHepatologybusiness.industryPatient SelectionAcute hepatitis CInterferon-alphaHIV InfectionsInterferon alpha-2Hepatitis CGastroenterologyRecombinant ProteinsPolyethylene GlycolsSurgeryInternal medicineAcute DiseasemedicineHumansAcute hepatitis Cbusiness
researchProduct

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities

2017

medicine.medical_specialtyHepatologybusiness.industryPneumonia PneumocystisPNEUMOCYSTIS JIROVECIGastroenterologyInflammatory Bowel DiseasesPneumocystis cariniimedicine.diseaseInflammatory bowel diseaseGastroenterology03 medical and health sciencesPneumonia0302 clinical medicine030228 respiratory systemConcomitantInternal medicineHumansMedicine030211 gastroenterology & hepatologybusinessClinical Gastroenterology and Hepatology
researchProduct

The use of infliximab in pediatric ulcerative colitis: A retrospective survey

2006

medicine.medical_specialtyHepatologybusiness.industryRetrospective surveyInternal medicineGastroenterologyMedicinePediatric ulcerative colitisbusinessInfliximabmedicine.drugDigestive and Liver Disease
researchProduct

Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: The HEPAIG study

2010

Acute hepatitis C continues to be a concern in men who have sex with men (MSM), and its optimal management has yet to be established. In this study, the clinical, biological, and therapeutic data of 53 human immunodeficiency virus (HIV)-infected MSM included in a multicenter prospective study on acute hepatitis C in 2006-2007 were retrospectively collected and analyzed. The mean hepatitis C virus (HCV) viral load at diagnosis was 5.8 ± 1.1 log10 IU/mL (genotype 4, n = 28; genotype 1, n = 14, genotype 3, n = 7). The cumulative rates of spontaneous HCV clearance were 11.0% and 16.5% 3 and 6 months after diagnosis, respectively. Forty patients were treated, 38 of whom received pegylated interf…

medicine.medical_specialtyHepatologybusiness.industryRibavirinHepatitis C virusvirus diseasesHepatitis CHepatologymedicine.diseasemedicine.disease_causeGastroenterologydigestive system diseasesMen who have sex with menchemistry.chemical_compoundchemistryPegylated interferonInternal medicineImmunologymedicineProspective cohort studybusinessViral loadmedicine.drugHepatology
researchProduct

Early menopausal status is associated with the severity of liver fibrosis in Italian patients with non-alcoholic fatty liver disease

2014

medicine.medical_specialtyHepatologybusiness.industrySettore MED/12 - GASTROENTEROLOGIALiver fibrosisFatty liverGastroenterologyNon alcoholicDiseasemedicine.diseaseGastroenterologyInternal medicinemedicinebusinessDigestive and Liver Disease
researchProduct

Visceral adiposity index and exercise in non-alcoholic fatty liver disease: authors’ reply

2012

We thank Prof. Filik for his interest in our recent article. 2 He points to the fact that the interpretation of our results could be affected by lack of data on physical activity and diet. In response to this issue, we are aware that both physical activity and diet are able to affect not only anthropometric and metabolic parameters of visceral adiposity index (VAI) but also the severity of liver disease. Unfortunately, data on both physical activity and diet in our patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD) are not available, even if we are confident that their variations should not significantly affect our results. In fact, in our study, we evaluated histological…

medicine.medical_specialtyHepatologybusiness.industrySurrogate endpointFatty liverGastroenterologyNon alcoholicDiseaseAnthropometrymedicine.diseaseGastroenterologyLiver diseaseEndocrinologyInternal medicineMedicinePharmacology (medical)Liver damagebusinessMETABOLIC FEATURESAlimentary Pharmacology & Therapeutics
researchProduct